HOME >> MEDICINE >> NEWS
Therapy program export treats borderline personality disorder

Trade between countries usually involves products. However, one successful export from the United States to the Netherlands, Norway and several other countries is a cognitive therapy treatment program created by University of Iowa experts to help people with borderline personality disorder.

The treatment program, called Systems Training for Emotional Predictability and Problem-Solving (STEPPS), augments standard treatment -- medication and individualized psychotherapy -- in order to give people with borderline personality disorder techniques to raise self-awareness and self-management.

People with the disorder struggle to manage intense emotions, experience frequent suicidal thoughts and can engage in self-damaging, impulsive behaviors. Their relationships with others are often unstable because of inconsistent or intense moods.

Borderline personality disorder, characterized in the STEPPS program as emotional intensity disorder, is found all over the world at about the same prevalence rate, said Nancee Blum, social work specialist in psychiatry in the UI Roy J. and Lucille A. Carver College of Medicine. Blum pioneered the treatment program along with colleagues Don St. John, UI physician assistant in psychiatry; Norm Bartels, a clinician in Wheaton, Ill.; and Bruce Pfohl, M.D., UI professor of psychiatry.

"Borderline personality disorder crosses many cultural lines. Sharing a treatment approach to benefit patients and experts in other countries has been exciting and gratifying," said Blum, who also is an adjunct faculty member in the UI College of Nursing and the School of Social Work in the UI College of Liberal Arts and Sciences.

Recently, experts in the Netherlands reported that 80 percent of their mental health facilities now have STEPPS-trained therapists using the Dutch version of STEPPS. In April, Blum will go to London to introduce the program to clinicians there. Meanwhile, the STEPPS manual is being translated for us
'"/>

Contact: Becky Soglin
becky-soglin@uiowa.edu
319-335-6660
University of Iowa
29-Mar-2006


Page: 1 2 3

Related medicine news :

1. Therapy is not one size fits all
2. Innovative Cancer Therapy for Tomorrow
3. MGH named by NHLBI as Specialized Center for Cell-Based Therapy for Heart, Lung and Blood Diseases
4. Therapy may not be necessary for autoimmune hepatitis with no symptoms
5. Therapy to overcome fears helps children with obsessive-compulsive disorder
6. Vicente Fox Center and RAND launch joint program to find policies to combat poverty
7. Scaling up HIV prevention programs is cost effective
8. Case study: cross-cultural bioethics training program helps fight African brain drain
9. Benefits of school-based fitness programs fade after summer
10. Energy Up demonstrates success as obesity intervention program for inner-city girls
11. Web-based program could ease treatment decisions for prostate cancer patients

Post Your Comments:
(Date:11/18/2014)... Nov. 17, 2014 (HealthDay News) -- Hispanic women who,ve had ... a certain type of heart trouble than those who,ve had ... team of researchers led by Shivani Aggarwal of Wake Forest ... and older, from Chicago, Miami, New York City and San ... at least six children. A type of heart trouble ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... people on the verge of burning out are more likely ... suffering from so-called vital exhaustion -- a toxic combination of ... risk of developing heart disease, researchers report. "In our ... And I think, when that stress is left unchecked for ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... Sierra Leone who became infected with Ebola in his native country ... Martin Salia had arrived Saturday at Nebraska Medical Center in Omaha. ... hospital in Sierra Leone,s capital city of Freetown. Sierra Leone, ... been ravaged by the Ebola outbreak that began last spring and ...
(Date:11/18/2014)... Randy Dotinga HealthDay Reporter ... use smartphone apps that help them track how many calories ... people who used a popular one after their doctor recommended ... conclusively debunk the idea of using such apps as weight-loss ... and their level of motivation varied, the researchers noted, and ...
(Date:11/17/2014)... 17, 2014 Vernon Brewer, Founder and President ... last two weeks and saw firsthand the devastating holocaust that ... in Iraq and Syria. , “‘Holocaust’ is not a term ... killed or driven thousands of Christians and members of other ... situation is desperate. As ISIS expands, they continue to ...
Breaking Medicine News(10 mins):Health News:Certain Heart Dysfunction More Likely in Hispanic Women With Many Kids: Study 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 3Health News:Doctor With Ebola Dies at Nebraska Hospital 2Health News:Calorie-Tracking Apps May Not Help You Lose Weight 2Health News:Calorie-Tracking Apps May Not Help You Lose Weight 3Health News:President of WORLD HELP Travels to Iraq and Jordan; Finds Religious Holocaust Being Executed by ISIS 2Health News:President of WORLD HELP Travels to Iraq and Jordan; Finds Religious Holocaust Being Executed by ISIS 3
(Date:11/18/2014)... Tocagen Inc. today announced that ... free survival at six months for recurrent high grade ... FC, compared to published benchmarks. HGG includes glioblastoma, the ... The data were delivered in an oral presentation at the ... of the Society for Neuro-Oncology (SNO) by Tim ...
(Date:11/17/2014)... CHARLOTTESVILLE, Va. , Nov. 17, 2014 HemoShear ... present at the 6th annual Partnering for Cures ... New York City . Marshall Summar , MD, ... Brian Wamhoff , PhD, Vice President of R&D and Co-founder ... of new rare disease treatments in less time and with ...
(Date:11/17/2014)... , Nov. 17, 2014   Wilson Therapeutics ... the start of a Phase 2 clinical study to ... WTX101 in Wilson Disease, a rare genetic disorder and ... to process copper. "We are delighted to ... patients as a next step in the development program ...
Breaking Medicine Technology:Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 2Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 3Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 4Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 5HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Discovery 2HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Discovery 3HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Discovery 4Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 2Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 3
Cached News: